Photo Credit: Rapeepong Puttakumwong / Getty Images
SOURCES:
American College of Cardiology: “Latest Evidence on Racial Inequities and Biases in Advanced Heart Failure.”
American Journal of Preventive Cardiology: “Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.”
CDC: “The Syphilis Study at Tuskegee Timeline.”
Circulation: Heart Failure: “Factors Associated with Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review.”
Clyde Yancy, MD, vice dean of Diversity & Inclusion; chief of the Division of Cardiology, Northwestern University, Feinberg School of Medicine.
FDA: “FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials.”
JAMA Cardiology: “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials,” “Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action from the Heart Failure Collaboratory.”
Journal of the American Heart Association: “Recruitment of Black Adults into Cardiovascular Disease Trials.”
Martin Mendoza, PhD, director of health equity, All of Us research program, National Institutes of Health.
Patrice Desvigne-Nickens, MD, medical officer, Division of Cardiovascular Science’s Heart Failure and Arrhythmias Branch, National Heart, Lung, and Blood Institute.
National Institutes of Health: “NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.”
